Simcere Pharmaceutical Group to Announce Second Quarter 2013 Financial Results on Tuesday, August 13, 2013

NANJING, China, July 29, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2013 on Tuesday, August 13, 2013, before the market opens in the United States. Simcere's management will host an earnings conference call on the same day at 8 a.m. ET (Tuesday, August 13 at 8 p.m. Beijing/Hong Kong time).

To access the conference call, please dial:

International toll:


United States toll-free:


United States toll:


China Domestic toll:


China Domestic mobile toll:


Hong Kong toll:


Please ask to be connected to Q2 2013 Simcere Pharmaceutical Group Earnings Conference Call and provide the following passcode: 23263347.

Simcere will also broadcast a live audio webcast of the conference call. The broadcast will be available by visiting the "Investor Relations" section of the company's web site at

Following the earnings conference call, an archive of the call will be available by dialing:

United States toll-free:

+1. 855.452.5696

United States toll:

+1. 646.254.3697

 The passcode for replay participants is 23263347. The telephone replay also will be archived on the "Investor Relations" section of the company's website for seven days following the earnings announcement.

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group (NYSE: SCR, Simcere) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, cardiovascular disease, infectious diseases and pain. For more information about Simcere Pharmaceutical Group, please visit

Investor and Media Contacts:


In Nanjing:
Jie Liu D'Elia
Vice President
Simcere Pharmaceutical Group

Tel: 86-25-8556-6666*8857


In Beijing:
Yue Yu

Brunswick Group

Tel: 86-10-5960-8600

In the United States:

Cindy Zheng

Brunswick Group

Tel: 1-212-333-3810




SOURCE Simcere Pharmaceutical Group


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.


PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.